Sun Pharma shares crash 8.5% amid reports of fresh whistleblower complaint

Pharma major Sun Pharmaceutical Industries on Friday said it has not received the alleged 172-page whistleblower complaint a media article talked about. “We are not privy to the contents of the document being referred (to) in the said media article,” it said. Sun Pharma responded to a BSE query that sought sequence of events in a chronological order and the material impact of any such development.


READ  Sales of scooters slip for first time in 13 years, PV segment sees slowest pace in 5 years


Please enter your comment!
Please enter your name here